Literature DB >> 30825249

Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.

Fiona Poyer1, Waltraud Friesenbichler1, Caroline Hutter1,2, Herbert Pichler1, Michael Dworzak1,2, Christina Peters1, Georg Mann1, Alexander Indra3, Andishe Attarbaschi1.   

Abstract

Rothia mucilaginosa is part of the oral and upper respiratory tract flora. Usually, this gram-positive coccus is not pathogenic; however, in the setting of immunosuppressed hosts, it can cause life-threatening infections as an opportunistic pathogen. Among a cohort of 1511 hematologic-oncologic patients at a pediatric tertiary care cancer center, we identified five cancer patients (0.35%) within a period of 10 years having a proven Rothia mucilaginosa bacteremia (1 culture positive: n = 3/5; > 1 culture positive: n = 2/5). With prompt and adequate antibiotic treatment, infection resolved rapidly before recovery of neutrophils and without any sequelae, suggesting that Rothia mucilaginosa bacteremia without organ involvement is not exceptionally problematic in pediatric cancer patients.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Rothia mucilaginosa; bacteremia; chemotherapy; flora; infection; neutropenia

Year:  2019        PMID: 30825249     DOI: 10.1002/pbc.27691

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

2.  Synanthropic spiders, including the global invasive noble false widow Steatoda nobilis, are reservoirs for medically important and antibiotic resistant bacteria.

Authors:  John P Dunbar; Neyaz A Khan; Cathy L Abberton; Pearce Brosnan; Jennifer Murphy; Sam Afoullouss; Vincent O'Flaherty; Michel M Dugon; Aoife Boyd
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.